Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04426526 · ClinicalTrials.gov registry record · NA
HIFEM for Arms, Lower Limbs, and Oblique Muscles
A NA study of Muscle Tone Increased, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 2
- Study locations
NCT04426526: Completed NA study of Muscle Tone Increased, sponsored by BTL Industries.
NCT04426526 is a NA study of Muscle Tone Increased that has completed, run by BTL Industries. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04426526, a NA study of Muscle Tone Increased, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 2
- Study locations
Study Summary
Evaluation of HIFEM treatments for strengthening and toning of arms, lower limbs and oblique muscles.
Primary Outcome
To determine the effectiveness of the device for strengthening and toning of arms, lower limbs and oblique muscles through changes in surrounding tissues, measured via ultrasound imaging. Using the obtained images, change in adipose and muscular tissues before and after the therapy sessions will be compared for every participant according to the study phase.
Conditions Studied
Interventions
- DEVICE BTL 799-2
Study Locations (2)
Colorado
- Plastic Surgical Associates - Fort Collins
New York
- Juva Skin & Laser Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-05-08 |
| Est. Completion | 2020-12-08 |
| Phase | NA |
What the finished NCT04426526 record still lists
NCT04426526 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Muscle Tone Increased appearing as the primary indexed condition, and to 1 intervention - of which BTL 799-2 is the first listed.
NCT04426526 reports a single indexed study location in Colorado, New York.
Frequently Asked Questions
What is clinical trial NCT04426526 about?
NCT04426526 is a clinical study titled "HIFEM for Arms, Lower Limbs, and Oblique Muscles". Evaluation of HIFEM treatments for strengthening and toning of arms, lower limbs and oblique muscles.
What is the current status of trial NCT04426526?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2019-05-08. Estimated completion is 2020-12-08.
What conditions does trial NCT04426526 study?
This clinical trial studies the following conditions: Muscle Tone Increased.
What interventions are being tested in trial NCT04426526?
The interventions under investigation include: BTL 799-2 (DEVICE).
Who is sponsoring clinical trial NCT04426526?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04426526 being conducted?
This trial has 2 study locations across Colorado, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Tone Increased
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04426526's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI